# Ocugen, Inc.: filings

OCGN · Nasdaq · CIK 1372299 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ocgn.md) · [Financials](/companies/ocgn/financials.md) · [Filings](/companies/ocgn/filings.md) · [Insiders](/companies/ocgn/insiders.md)

## Reports and events: 362 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 277, 4 240, 3 43, 10-Q 35, DEFA14A 33, 425 22, SC 13G/A 19, 424B5 18, CORRESP 16, DEF 14A 15, S-8 14, UPLOAD 13, 10-K 12, SC 13G 11, EFFECT 9, SC 13D/A 8, PRE 14A 7, S-3 7, D 6, 144 5, 424B3 5, DRS/A 5, 8-K/A 4, ARS 4, CT ORDER 4, S-1/A 4, SC 13D 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, 10-K/A 2, 3/A 2, PRER14A 2, S-4/A 2, SEC STAFF LETTER 2, 10-Q/A 1, 424B4 1, 424B7 1, 4/A 1, 8-A12B 1, 8-A12G 1, CERTNAS 1, D/A 1, DEFR14A 1, DRS 1, FWP 1, NT 10-K 1, NT 10-Q 1, POS AM 1, POSASR 1, RW 1, S-1 1, S-3/A 1, S-3ASR 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 12:01 ET | [8-K](/filings/0001104659-26-115970.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115970 |
| 2026-10-15 | 01:22 ET | [8-K](/filings/0001104659-26-115921.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115921 |
| 2026-10-06 | 21:36 ET | [8-K](/filings/0001628280-26-065077.md) | 5.07 Shareholder vote results | 0001628280-26-065077 |
| 2026-09-23 | 21:34 ET | [8-K](/filings/0001628280-26-063084.md) | 5.07 Shareholder vote results | 0001628280-26-063084 |
| 2026-09-08 | 21:27 ET | [8-K](/filings/0001104659-26-105968.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-105968 |
| 2026-08-06 | 16:15 ET | [10-Q](/filings/0001628280-26-054057.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054057 |
| 2026-08-06 | 12:30 ET | [8-K](/filings/0001104659-26-091691.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091691 |
| 2026-07-30 | 20:30 ET | [DEF 14A](/filings/0001140361-26-030258.md) | Proxy statement, period 2026-09-21 | 0001140361-26-030258 |
| 2026-07-13 | 12:30 ET | [8-K](/filings/0001104659-26-082897.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082897 |
| 2026-06-11 | 21:19 ET | [8-K](/filings/0001104659-26-073015.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-073015 |
| 2026-06-03 | 20:30 ET | [8-K](/filings/0001104659-26-070124.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-070124 |
| 2026-05-14 | 20:31 ET | [8-K](/filings/0001104659-26-061241.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-26-061241 |
| 2026-05-14 | 20:30 ET | [8-K](/filings/0001104659-26-061230.md) | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-061230 |
| 2026-05-08 | 23:02 ET | [10-Q](/filings/0001628280-26-032454.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032454 |
| 2026-05-07 | 20:12 ET | [8-K](/filings/0001104659-26-057138.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-057138 |
| 2026-05-05 | 15:37 ET | [8-K](/filings/0001104659-26-055411.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-055411 |
| 2026-05-04 | 20:03 ET | [8-K](/filings/0001104659-26-054866.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-054866 |
| 2026-04-28 | 11:00 ET | [DEF 14A](/filings/0001140361-26-017260.md) | Proxy statement, period 2026-06-11 | 0001140361-26-017260 |
| 2026-03-27 | 23:13 ET | [8-K](/filings/0001628280-26-021541.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-021541 |
| 2026-03-24 | 16:02 ET | [8-K](/filings/0001104659-26-033724.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033724 |
| 2026-03-20 | 12:00 ET | [8-K](/filings/0001104659-26-032442.md) | 8.01 Other events | 0001104659-26-032442 |
| 2026-03-04 | 16:38 ET | [10-K](/filings/0001628280-26-014435.md) | Annual report, period 2025-12-31 | 0001628280-26-014435 |
| 2026-03-04 | 16:12 ET | [8-K](/filings/0001104659-26-023290.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023290 |
| 2026-03-04 | 16:07 ET | [8-K](/filings/0001104659-26-023288.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-023288 |
| 2026-02-09 | 12:59 ET | [8-K](/filings/0001104659-26-011765.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-011765 |
| 2026-01-23 | 13:12 ET | [8-K](/filings/0001104659-26-006031.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006031 |
| 2026-01-21 | 22:29 ET | [8-K](/filings/0001104659-26-005454.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-005454 |
| 2026-01-15 | 13:31 ET | [8-K](/filings/0001104659-26-003900.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003900 |
| 2025-12-18 | 22:17 ET | [8-K](/filings/0001104659-25-122610.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-122610 |
| 2025-11-05 | 14:41 ET | [10-Q](/filings/0001372299-25-000013.md) | Quarterly report, period 2025-09-30 | 0001372299-25-000013 |
| 2025-11-05 | 12:30 ET | [8-K](/filings/0001104659-25-106664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-106664 |
| 2025-09-18 | 15:00 ET | [8-K](/filings/0001104659-25-091097.md) | 1.02 Termination of a material agreement | 0001104659-25-091097 |
| 2025-09-16 | 23:50 ET | [8-K](/filings/0001104659-25-090113.md) | 1.01 Entry into a material agreement | 0001104659-25-090113 |
| 2025-09-05 | 20:11 ET | [8-K](/filings/0001104659-25-087801.md) | 1.01 Entry into a material agreement | 0001104659-25-087801 |
| 2025-08-11 | 12:35 ET | [8-K](/filings/0001104659-25-075956.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-075956 |
| 2025-08-04 | 12:29 ET | [10-Q](/filings/0001628280-25-037310.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037310 |
| 2025-08-01 | 16:23 ET | [8-K](/filings/0001104659-25-072992.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-072992 |
| 2025-07-30 | 20:36 ET | [8-K](/filings/0001104659-25-072197.md) | 8.01 Other events | 0001104659-25-072197 |
| 2025-07-29 | 10:30 ET | [8-K](/filings/0001104659-25-071374.md) | 8.01 Other events | 0001104659-25-071374 |
| 2025-07-01 | 19:49 ET | [8-K](/filings/0001104659-25-064695.md) | 3.01 Delisting notice | 0001104659-25-064695 |
| 2025-06-23 | 12:58 ET | [8-K](/filings/0001104659-25-061435.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-061435 |
| 2025-06-17 | 21:54 ET | [8-K](/filings/0001372299-25-000004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001372299-25-000004 |
| 2025-06-05 | 20:37 ET | [8-K](/filings/0001104659-25-056875.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-056875 |
| 2025-05-09 | 13:45 ET | [8-K](/filings/0001628280-25-024095.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-024095 |
| 2025-05-09 | 13:43 ET | [10-Q](/filings/0001628280-25-024093.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024093 |
| 2025-05-01 | 13:22 ET | [8-K](/filings/0001628280-25-021359.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-021359 |
| 2025-04-25 | 20:56 ET | [DEF 14A](/filings/0001140361-25-015803.md) | Proxy statement, period 2025-06-05 | 0001140361-25-015803 |
| 2025-04-25 | 20:45 ET | [8-K](/filings/0001104659-25-039478.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-039478 |
| 2025-04-04 | 13:23 ET | [8-K](/filings/0001628280-25-016700.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-016700 |
| 2025-03-05 | 14:42 ET | [10-K](/filings/0001628280-25-010271.md) | Annual report, period 2024-12-31 | 0001628280-25-010271 |

Page 1 of 8. [Older](/companies/ocgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.